Fenwal AMICUS Double Needle Advanced Kit 4R2354Recalls & reported problems
Fresenius Kabi AG · For Collection of Platelets with Optional Plasma. For Platelet Storage in Plasma or Platelet Additive Solution Plus Plasma. For Use with the AMICUS Separator. Sterile Fluid Path. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 04086000101387), received between Sep 27, 2019 and Aug 4, 2020 — classified as 1 injury, 3 malfunctions.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available4
Patient problems
- No Consequences Or Impact To Patient3
- Reaction to Medicinal Component of Device1
- Sepsis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryAug 4, 2020Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
CUSTOMER (AMERICAN RED CROSS ARC) REPORTED :AMICUS PLATELET COLLECTED ON 06/20/2020 (EXP. 06/25/2020), AMICUS LOT FA20D28132. COLLECTED IN FACILITY 018, MANUFACTURED IN FACILITY 016. TWO PLATELET PRODUCTS FROM THIS DONATION, PCODE E7002V00 WAS DISTRIBUTED TO A HOSPITAL IN (B)(6) AND WAS TRANSFUSED WITHOUT INCIDENT. PRODUCT E7003V00 WAS SHIPPED TO A HOSPITAL IN (B)(6) FOLLOWING A SITE TO SITE SHIPMENT FROM (B)(6). BACT TESTING WAS NEGATIVE AFTER 5 DAYS, HOSPITAL VERBALLY REPORTED A SEPTIC TRANSFUSION REACTION TO DCSC ON (B)(6) 2020. ON 06/30/2020, DCSC WAS NOTIFIED PATIENT POST TRANSFUSION CULTURE AND RESIDUAL PRODUCT CULTURES ARE POSITIVE FOR ACINETOBACTER HAEMOLYTICUS. THIS NOT A FATALITY. ARC INTERNAL NUMBER IS (B)(4). FROM ARC: THE PLATELET WAS COLLECTED BY (B)(6) REGION. TWO PLATELETS (CO-COMPONENTS) WERE MANUFACTURED BY (B)(6) REGION - 1 CO-COMPONENT WAS TRANSFUSED IN (B)(6) REGION HOSPITAL WITHOUT INCIDENT AND 1 CO-COMPONENT WAS SHIPPED TO (B)(6) REGION AND TRANSFUSED IN A (B)(6) HOSPITAL WHICH REPORTED THE TRANSFUSION REACTION.
Patient problems: Reaction to Medicinal Component of Device; Sepsis
MAUDE report 10364376 ↗MalfunctionSep 27, 2019Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
CUSTOMER REPORTED THE UNIT COLLECTED DURING DONATION TESTED POSITIVE FOR PROPIONIBACTERIUM ACNES(A). THE MICROORGANISMS WERE FOUND IN THE PLATELET STORAGE BAGS. THE TIME INTERVAL THAT THESE MICROORGANISMS WERE FOUND WAS 4.5 DAYS. DOUBLE PRODUCT; NO BAG ATTACHED; SAMPLING DEVICE STERILE WELDED. INVESTIGATION 599817 WAS COMPLETED. NO SAMPLES WERE RECEIVED FOR ANALYSIS. HOWEVER, MICROBIOLOGICAL TESTING RESULTS WERE REVIEWED FOR AMICUS BATCH FA19E06138 MANUFACTURING PERIOD, INCLUDING PREVIOUS MONTH. NO OUT OF LIMIT IS OBSERVED IN THE 12-MONTH TIMEFRAME. A MICROBIOLOGY TESTING EXTERNAL SUPPLIER, PACE ANALYTICAL, COMPLETED ADDITIONAL TESTING TO THE AMICUS MANUFACTURING AREAS, INCLUDING THE FOLLOWING SAMPLING: - ENVIRONMENTAL MONITORING AIR SAMPLES - SURFACE MONITORING SWABS - ORGANISM IDENTIFICATION THE SAME SAMPLING WAS TAKEN BY THE HAINA MICROBIOLOGY LAB TEAM, TO REVIEW THE CURRENT AMICUS CONDITIONS. ROOT CAUSE IDENTIFIED: THE AMICUS MICROBIOLOGY TESTING WAS COMPLETED WITH SATISFACTORY RESULTS. THE BACTERIA IDENTIFIED BY THE CUSTOMER IS NOT PART OF THE HAINA PLANT MICRO-FLORA. IN ADDITION, THE MICROBIOLOGY MONITORING IS WITHIN ESTABLISHED LIMIT. CURRENT CONTROLS: - MICROBIOLOGY MONITOR
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9130455 ↗MalfunctionSep 27, 2019Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
CUSTOMER REPORTED THE UNIT COLLECTED DURING DONATION TESTED POSITIVE FOR GRAM+ RODS RESEMBLING BACILLUS. THE MICROORGANISMS WERE FOUND IN THE PLATELET STORAGE BAGS. THE TIME INTERVAL THAT THESE MICROORGANISMS WERE FOUND WAS 17.2 HOURS. SINGLE PRODUCT; NO BAG ATTACHED; SAMPLING DEVICE STERILE WELDED. INVESTIGATION 599817 WAS COMPLETED. NO SAMPLES WERE RECEIVED FOR ANALYSIS. HOWEVER, MICROBIOLOGICAL TESTING RESULTS WERE REVIEWED FOR AMICUS BATCH FA19E06138 MANUFACTURING PERIOD, INCLUDING PREVIOUS MONTH. NO OUT OF LIMIT IS OBSERVED IN THE 12-MONTH TIMEFRAME. A MICROBIOLOGY TESTING EXTERNAL SUPPLIER, PACE ANALYTICAL, COMPLETED ADDITIONAL TESTING TO THE AMICUS MANUFACTURING AREAS, INCLUDING THE FOLLOWING SAMPLING: - ENVIRONMENTAL MONITORING AIR SAMPLES. - SURFACE MONITORING SWABS. - ORGANISM IDENTIFICATION. THE SAME SAMPLING WAS TAKEN BY THE HAINA MICROBIOLOGY LAB TEAM, TO REVIEW THE CURRENT AMICUS CONDITIONS. ROOT CAUSE IDENTIFIED: THE AMICUS MICROBIOLOGY TESTING WAS COMPLETED WITH SATISFACTORY RESULTS. THE BACTERIA IDENTIFIED BY THE CUSTOMER IS NOT PART OF THE HAINA PLANT MICRO-FLORA. IN ADDITION, THE MICROBIOLOGY MONITORING IS WITHIN ESTABLISHED LIMIT. CURRENT CONTROLS: - MICROBIOLOG
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9130454 ↗MalfunctionSep 27, 2019Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
CUSTOMER REPORTED THE UNIT COLLECTED DURING DONATION TESTED POSITIVE FOR LISTERIA MONOCYTOGENES (AA). THE MICROORGANISMS WERE FOUND IN THE PLATELET STORAGE BAGS. THE TIME INTERVAL THAT THESE MICROORGANISMS WERE FOUND WAS 16.9 HOURS. TRIPLE PRODUCT; BAG ATTACHED; SAMPLING DEVICE STERILE WELDED. INVESTIGATION 599817 WAS COMPLETED. NO SAMPLES WERE RECEIVED FOR ANALYSIS. HOWEVER, MICROBIOLOGICAL TESTING RESULTS WERE REVIEWED FOR AMICUS BATCH FA19E06138 MANUFACTURING PERIOD, INCLUDING PREVIOUS MONTH. NO OUT OF LIMIT IS OBSERVED IN THE 12-MONTH TIMEFRAME. A MICROBIOLOGY TESTING EXTERNAL SUPPLIER, PACE ANALYTICAL, COMPLETED ADDITIONAL TESTING TO THE AMICUS MANUFACTURING AREAS, INCLUDING THE FOLLOWING SAMPLING: - ENVIRONMENTAL MONITORING AIR SAMPLES - SURFACE MONITORING SWABS - ORGANISM IDENTIFICATION THE SAME SAMPLING WAS TAKEN BY THE HAINA MICROBIOLOGY LAB TEAM, TO REVIEW THE CURRENT AMICUS CONDITIONS. ROOT CAUSE IDENTIFIED: THE AMICUS MICROBIOLOGY TESTING WAS COMPLETED WITH SATISFACTORY RESULTS. THE BACTERIA IDENTIFIED BY THE CUSTOMER IS NOT PART OF THE HAINA PLANT MICRO-FLORA. IN ADDITION, THE MICROBIOLOGY MONITORING IS WITHIN ESTABLISHED LIMIT. CURRENT CONTROLS: - MICROBIOLOGY MONITOR
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9130453 ↗
Other Separator, Automated, Blood Cell, Diagnostic devices
- Trima Accel® 82406Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic470 reports
- Trima Accel® 82446Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic1 death300 reports
- Trima Accel® 81000Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic150 reports
- Spectra Optia® 12220Terumo Bct, Inc. · Separator, Automated, Blood Cell, Diagnostic14 deaths147 reports
- Spectra Optia® 12320Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic2 deaths119 reports
- Trima Accel® 80400Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic109 reports
- Spectra Optia® 10310Terumo Bct, Inc. · Separator, automated, blood cell, diagnostic6 deaths103 reports
- HAEMONETICS PCS 300 PLASMA COLLECTION SYSTEM PCS-300-USHaemonetics Corporation · Separator, automated, blood cell, diagnostic18 deaths101 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page